Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Diana Abbott and Ajay Major.

 
Connection Strength
 
 
 
0.617
 
  1. Major A, Abbott D, Snyder J, Ahmed N, Nogueira Serodio A, Villasboas JC, Sharp J, Voorhees TJ, Houshyar S, Wallace DS, Adhikari A, Patel D, Wanjiku CM, Wagner CB, Bock AM, Brooks TR, Al Any H, Tsang M, Rajab M, Iqbal M, Desai N, Gupta S, Altomare N, Karmali R, Trotier D, Pophali PA, Ricker E, Cherng HJ, Chicola JA, Torka P, Keenan JC, Trabolsi A, Schatz JH, Gupta A, Hill BT. Comparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL. Blood Adv. 2026 Oct 30.
    View in: PubMed
    Score: 0.249
  2. Allen J, Abbott D, Eskandar J, Bair SM, Haverkos B, Jasem J, Kamdar M, Major A. DA-R-EPOCH May Mitigate the Adverse Prognostic Implication of the Diagnosis-to-Treatment Interval (DTI) in Large B-Cell Lymphomas. Clin Lymphoma Myeloma Leuk. 2025 Jan; 25(1):e26-e33.
    View in: PubMed
    Score: 0.215
  3. Major A, Hammes A, Schmidt MQ, Morgan R, Abbott D, Kamdar M. Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma. Clin Lymphoma Myeloma Leuk. 2020 01; 20(1):39-46.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)